EUVIMEDEUVIMED entdecken
Open Access

Divergent splicing factor SRSF1 signaling promotes inflammation post-CME: the SRSF1/ENPP3 axis acts via inhibition of BRD4 O-GlcNAcylation to enhance NF-κB activation and accelerate heart failure

Chen-Kai Hu, Lei He, Wan-Zhong Huang, Yuan Huang, Ri-Xin Dai, Chen Chang, Jun-Xiong Qiu, Qiang Wu, Qiang Su

Theranostics · 2025

DOI: 10.7150/thno.115402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Chen-Kai Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, 330006, …. Hauptthemen laut MEDLINE: Serine-Arginine Splicing Factors, Heart Failure, NF-kappa B, Transcription Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Coronary microembolization (CME) is a severe medical condition that occurs during acute coronary syndrome, leading to myocardial inflammation, apoptosis, and cardiac dysfunction. The research investigated SRSF1 biological functions during myocardial inflammation caused by CME and its underlying mechanisms.

Methods

CME models were established in rats injected with microspheres in the left ventricle and oxygen-glucose deprivation (OGD)-exposed cardiomyocytes. RT-qPCR, Western blotting and immunohistochemical staining were used to evaluate the expression of target molecules. Myocardial apoptosis was detected by flow cytometry. The direct binding between SRSF1 and ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) was verified by RIP and TRAP. Protein interaction was determined by Co-IP. The dual-luciferase reporter assay measured inflammatory cytokine transcription levels. Myocardial injury was assessed by HE staining and ultrasound examinations. The study used ELISA to measure inflammatory cytokines and cardiac troponin I (cTnI) levels.

Results

SRSF1 expression was strikingly enhanced in CME models. Knockdown of SRSF1 effectively restrained NF-κB-mediated myocardial inflammation through increasing ENPP3 mRNA/lncRNA ENPP3 ratio by regulating alternative splicing of ENPP3 pre-mRNA. The GlcNAcylation of bromodomain-containing protein 4 (BRD4) was reduced during CME, which increased BRD4 protein level to trigger NF-κB-mediated inflammation. SRSF1/ENPP3 axis inhibited the GlcNAcylation of BRD4 in CME. Myocardial-specific knockout of SRSF1 restored cardiac function and restrained myocardial inflammation in CME rats by inactivation of the ENPP3/BRD4/NF-κB pathway.

Conclusions

SRSF1 facilitates CME-induced myocardial inflammation by up-regulating ENPP3/lncRNA ENPP3 ratio to suppress GlcNAcylation of BRD4, suggesting SRSF1 inhibition as a promising therapeutic strategy for CME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine-Arginine Splicing FactorsHeart FailureNF-kappa BTranscription FactorsInflammationCell Cycle ProteinsAnimalsRatsSignal TransductionMaleRats, Sprague-DawleyMyocytes, CardiacApoptosisDisease Models, AnimalHumansBromodomain Containing ProteinsNuclear Proteins

Stichwörter der Autor:innen

BRD4ENPP3SRSF1coronary microembolizationinflammation

Substanzen

Serine-Arginine Splicing FactorsNF-kappa BTranscription FactorsBrd4 protein, ratCell Cycle ProteinsBromodomain Containing ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, 330006, China.
  • Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, No. 85 Hedi Road, Nanning, Guangxi, 530021, China.
  • Department of Cardiology, the First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541001, China.
  • Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Senior Department of Cardiology, the Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China.

Zitieren

APA

Hu, C. K., He, L., Huang, W. Z., Huang, Y., Dai, R. X., Chang, C., Qiu, J. X., Wu, Q., & Su, Q. (2025). Divergent splicing factor SRSF1 signaling promotes inflammation post-CME: the SRSF1/ENPP3 axis acts via inhibition of BRD4 O-GlcNAcylation to enhance NF-κB activation and accelerate heart failure. Theranostics. https://doi.org/10.7150/thno.115402

Vancouver

Hu CK, He L, Huang WZ, Huang Y, Dai RX, Chang C, et al. Divergent splicing factor SRSF1 signaling promotes inflammation post-CME: the SRSF1/ENPP3 axis acts via inhibition of BRD4 O-GlcNAcylation to enhance NF-κB activation and accelerate heart failure. Theranostics. 2025. doi:10.7150/thno.115402

BibTeX
@article{Hu2025,
  author = {Hu, Chen-Kai and He, Lei and Huang, Wan-Zhong and Huang, Yuan and Dai, Ri-Xin and Chang, Chen and Qiu, Jun-Xiong and Wu, Qiang and Su, Qiang},
  title = {Divergent splicing factor SRSF1 signaling promotes inflammation post-CME: the SRSF1/ENPP3 axis acts via inhibition of BRD4 O-GlcNAcylation to enhance NF-κB activation and accelerate heart failure},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.115402}
}
Kostenlos starten →